Clinical Trial Update: Short and Optimal Duration of Dual Antiplatelet Therapy Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the optimal and shorter duration of dual antiplatelet therapy in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Takeshi Morimoto | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED